|
DE2848965A1
(de)
|
1978-11-11 |
1980-05-22 |
Behringwerke Ag |
Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
|
|
US6699474B1
(en)
|
1990-08-20 |
2004-03-02 |
Erich Hugo Cerny |
Vaccine and immunserum against drugs of abuse
|
|
DE69333110T2
(de)
|
1992-03-02 |
2004-05-06 |
Chiron S.P.A. |
Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
|
|
NL9201716A
(nl)
|
1992-10-02 |
1994-05-02 |
Nederlanden Staat |
Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.
|
|
FR2718452B1
(fr)
|
1994-04-06 |
1996-06-28 |
Pf Medicament |
Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
|
|
JPH10502365A
(ja)
|
1994-07-01 |
1998-03-03 |
リカン・リミテッド |
ヘリコバクタータンパク質およびワクチン
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
IL117483A
(en)
|
1995-03-17 |
2008-03-20 |
Bernard Brodeur |
MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
|
|
US6180111B1
(en)
|
1995-05-18 |
2001-01-30 |
University Of Maryland |
Vaccine delivery system
|
|
AU712213B2
(en)
*
|
1995-09-22 |
1999-11-04 |
Connaught Laboratories Limited |
Parainfluenza virus glycoproteins and vaccines
|
|
WO1997025429A1
(en)
|
1996-01-04 |
1997-07-17 |
Rican Limited |
Helicobacter pylori bacterioferritin
|
|
RS50101B
(sr)
*
|
1996-02-24 |
2009-01-22 |
Boehringer Ingelheim International Gmbh., |
Farmaceutski preparati za imunomodulaciju
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
WO1998053851A1
(en)
|
1997-05-28 |
1998-12-03 |
University Of Iowa Research Foundation |
Laft mutants of pathogenic gram-negative bacteria
|
|
GB9711964D0
(en)
|
1997-06-09 |
1997-08-06 |
Medical Res Council |
Live attenuated vaccines
|
|
EP0991761B1
(en)
|
1997-08-21 |
2008-01-16 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Novel mutants of gram negative mucosal bacteria and application thereof in vaccines
|
|
DE19803453A1
(de)
*
|
1998-01-30 |
1999-08-12 |
Boehringer Ingelheim Int |
Vakzine
|
|
US6645503B1
(en)
|
1998-03-10 |
2003-11-11 |
Wyeth Holdings Corporation |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
|
|
EP2261352A3
(en)
|
1998-05-01 |
2012-01-04 |
Novartis Vaccines and Diagnostics, Inc. |
Neisseria meningitidis antigens and compositions
|
|
WO2000023595A1
(en)
|
1998-10-22 |
2000-04-27 |
The University Of Montana |
Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
|
|
GB9823978D0
(en)
|
1998-11-02 |
1998-12-30 |
Microbiological Res Authority |
Multicomponent meningococcal vaccine
|
|
AU762369B2
(en)
|
1998-11-03 |
2003-06-26 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur |
LPS with reduced toxicity from genetically modified gram negative bacteria
|
|
JP2003518363A
(ja)
|
1999-04-30 |
2003-06-10 |
カイロン エセ．ピー．アー． |
保存されたナイセリア抗原
|
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
US6531131B1
(en)
|
1999-08-10 |
2003-03-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugate vaccine for Neisseria meningitidis
|
|
WO2001034642A2
(en)
|
1999-11-12 |
2001-05-17 |
University Of Iowa Research Foundation |
Control of neisserial membrane synthesis
|
|
CA2390344C
(en)
|
1999-11-29 |
2014-08-26 |
Chiron Spa |
85kda neisserial antigen
|
|
PT2289545T
(pt)
|
2000-01-17 |
2016-09-06 |
Glaxosmithkline Biologicals Sa |
Vacina de omv suplementada contra meningococos
|
|
PL216780B1
(pl)
|
2000-01-25 |
2014-05-30 |
Univ Queensland Of Santa Lucia |
Wyizolowane białka zawierające konserwatywne obszary antygenu powierzchniowego NhhA z Neisseria meningitidis, białka fuzyjne, kompozycja farmaceutyczna, przeciwciało monoklonalne lub wiążący antygen fragment przeciwciała monoklonalnego, wyizolowany kwas nukleinowy, konstrukt ekspresyjny, komórka gospodarza, sposób wytwarzania rekombinowanego białka, sposób wykrywania N. meningitidis w próbce biologicznej, sposób diagnozowania zakażenia N. meningitidis oraz sposób wykrywania N. meningitidis w próbce biologicznej uzyskanej od pacjenta oraz zastosowanie wyizolowanego białka, białka fuzyjnego i konstruktu ekspresyjnego
|
|
NO20002828D0
(no)
|
2000-06-02 |
2000-06-02 |
Statens Inst For Folkehelse |
Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
|
|
AU2001281812B2
(en)
|
2000-06-08 |
2005-04-07 |
Valneva Austria Gmbh |
Immunostimulatory oligodeoxynucleotides
|
|
WO2002002606A2
(en)
|
2000-07-03 |
2002-01-10 |
Chiron S.P.A. |
Immunisation against chlamydia pneumoniae
|
|
US6936261B2
(en)
|
2000-07-27 |
2005-08-30 |
Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
|
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
AT410635B
(de)
|
2000-10-18 |
2003-06-25 |
Cistem Biotechnologies Gmbh |
Vakzin-zusammensetzung
|
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
|
FR2827605B1
(fr)
|
2001-07-20 |
2004-07-16 |
Pf Medicament |
Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin
|
|
CA2452720C
(en)
|
2001-07-26 |
2012-04-17 |
Chiron S.R.L. |
Vaccines comprising aluminium adjuvants and histidine
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
CN100515494C
(zh)
|
2001-12-12 |
2009-07-22 |
启龙有限公司 |
抗沙眼衣原体的免疫
|
|
ATE419873T1
(de)
|
2002-02-22 |
2009-01-15 |
Ca Nat Research Council |
Synthese von lipopolysaccharid-protein konjugatvaccinen über die lipid-a region nach entfernung des glycosidischen phosphatresidüs
|
|
GB0211118D0
(en)
|
2002-05-15 |
2002-06-26 |
Polonelli Luciano |
Vaccines
|
|
GB0213622D0
(en)
|
2002-06-13 |
2002-07-24 |
Glaxosmithkline Biolog Sa |
Vaccine Corporation
|
|
EP1524991A1
(en)
|
2002-08-02 |
2005-04-27 |
GlaxoSmithKline Biologicals S.A. |
Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria
|
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
|
HUE031886T2
(en)
|
2002-10-11 |
2017-08-28 |
Glaxosmithkline Biologicals Sa |
Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
|
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
|
CN100355453C
(zh)
*
|
2003-03-24 |
2007-12-19 |
英特塞尔股份公司 |
改进的疫苗
|
|
ATE485056T1
(de)
*
|
2003-03-24 |
2010-11-15 |
Intercell Ag |
Verbesserte impfstoffe
|
|
CN1812809A
(zh)
|
2003-06-26 |
2006-08-02 |
希龙公司 |
用于沙眼衣原体的免疫原性组合物
|
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
|
CA2557353A1
(en)
|
2004-03-02 |
2005-09-15 |
Chiron Corporation |
Immunogenic compositions for chlamydia pneunomiae
|
|
GB0419408D0
(en)
|
2004-09-01 |
2004-10-06 |
Chiron Srl |
741 chimeric polypeptides
|
|
GB0419627D0
(en)
|
2004-09-03 |
2004-10-06 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
|
ES2616294T3
(es)
|
2005-01-27 |
2017-06-12 |
Children's Hospital & Research Center At Oakland |
Vacunas de vesículas basadas en GNA1870 para protección de amplio espectro contra enfermedades provocadas por Neisseria meningitidis
|
|
NZ599345A
(en)
|
2005-02-18 |
2013-07-26 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic Escherichia Coli
|
|
AU2006214064B2
(en)
*
|
2005-02-18 |
2012-04-26 |
J. Craig Venter Institute, Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
|
EP1891096A2
(en)
|
2005-05-12 |
2008-02-27 |
Novartis Vaccines and Diagnostics, Inc. |
Immunogenic compositions for chlamydia trachomatis
|
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
|
AU2006341122B2
(en)
|
2005-12-22 |
2013-08-22 |
Novartis Vaccines And Diagnostics, Srl. |
Chlamydial antigens
|
|
JP2009520771A
(ja)
|
2005-12-23 |
2009-05-28 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
コンジュゲートワクチン
|
|
DE602007003596D1
(de)
|
2006-06-12 |
2010-01-14 |
Glaxosmithkline Biolog Sa |
Impfstoff
|
|
WO2008020330A2
(en)
|
2006-08-16 |
2008-02-21 |
Novartis Ag |
Immunogens from uropathogenic escherichia coli
|
|
EP2227248B2
(en)
*
|
2007-11-26 |
2018-01-31 |
GlaxoSmithKline Biologicals SA |
Adjuvanted glucans
|
|
AU2008339631B2
(en)
|
2007-12-24 |
2014-07-24 |
Novartis Ag |
Assays for adsorbed influenza vaccines
|
|
CN102356089B
(zh)
|
2008-02-21 |
2014-02-19 |
诺华股份有限公司 |
脑膜炎球菌fHBP多肽
|
|
ITMI20081249A1
(it)
|
2008-07-09 |
2010-01-09 |
Novartis Vaccines & Diagnostic |
Immunogeni di escherichia coli con solubilità migliorata.
|
|
NZ591768A
(en)
|
2008-09-18 |
2012-11-30 |
Novartis Ag |
Vaccine adjuvant combinations
|